We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

84 hedge funds and large institutions have $78M invested in VanEck Biotech ETF in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,059% more call options, than puts

Call options by funds: $10M | Put options by funds: $865K

0.91% more ownership

Funds ownership: 19.62% → 20.54% (+0.91%)

3% less capital invested

Capital invested by funds: $80.7M → $78M (-$2.69M)

7% less funds holding

Funds holding: 90 → 84 (-6)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

71% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 28

Holders
84
Holders Change
-6
Holders Change %
-6.67%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
28
Closed
13
Calls
$10M
Puts
$865K
Net Calls
+$9.16M
Net Calls Change
+$3.27M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.44M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.13M
3
Bank of America
Bank of America
North Carolina
+$992K
4
B
Bailard
California
+$200K
5
IWC
Integrated Wealth Concepts
Massachusetts
+$199K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$2.75M
2
Morgan Stanley
Morgan Stanley
New York
-$1.21M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.08M
4
Wells Fargo
Wells Fargo
California
-$864K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$519K
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
26
Janney Montgomery Scott
Pennsylvania
$773K – – –
Ameriprise
27
Ameriprise
Minnesota
$735K -$43.9K -356 -6%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$709K – – –
SBH
29
Segall Bryant & Hamill
Illinois
$675K -$24.7K -200 -4%
PAG
30
Private Advisor Group
New Jersey
$645K -$83.8K -680 -12%
IFWM
31
Institute for Wealth Management
Colorado
$642K -$15.4K -125 -2%
TC
32
Telemus Capital
Michigan
$554K -$52.4K -425 -9%
FNBOSM
33
First National Bank of South Miami
Florida
$537K -$5.92K -48 -1%
IAMOG
34
Investors Asset Management of Georgia
Georgia
$477K – – –
SC
35
Scotia Capital
Ontario, Canada
$467K – – –
SB
36
Suntrust Banks
Georgia
$458K -$4.19K -34 -0.9%
WJA
37
Williams Jones & Associates
New York
$453K – – –
AB
38
Atlas Brown
Kentucky
$361K -$2.34K -19 -0.7%
First Manhattan
39
First Manhattan
New York
$303K +$24.7K +200 +9%
FFN
40
Focus Financial Network
Minnesota
$296K – – –
MML Investors Services
41
MML Investors Services
Massachusetts
$259K -$15.9K -129 -6%
MWA
42
MFA Wealth Advisors
Pennsylvania
$232K – – –
TCM
43
Tufton Capital Management
Maryland
$212K – – –
B
44
Bailard
California
$210K +$200K +1,626 New
IWC
45
Integrated Wealth Concepts
Massachusetts
$208K +$199K +1,617 New
FANJ
46
Financial Architects (New Jersey)
New Jersey
$203K – – –
TRCT
47
Tower Research Capital (TRC)
New York
$160K -$96.4K -782 -39%
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$160K – – –
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
$155K -$24.7K -200 -14%
Citigroup
50
Citigroup
New York
$146K +$21.2K +172 +18%
1
2
3 4

BBH Hedge Fund Activity: Q2 2019 in Review

84 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2019, worth a combined $78M — down 3.3% from $80.7M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BBH and 11 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 8 added.

The largest buyer was Susquehanna International Group, adding an estimated $3.44M. The largest seller was Virtu Financial, exiting entirely with an estimated $2.75M sold.

  • 84 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2019, down from 90 in Q1 2019.
  • Funds reported $78M of VanEck Biotech ETF stock for Q2 2019, down 3.3% quarter-over-quarter.
  • 11 funds opened new VanEck Biotech ETF positions in Q2 2019 and 13 closed out, a net change of -2 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2019 was Susquehanna International Group, an estimated $3.44M added.
  • The largest VanEck Biotech ETF seller in Q2 2019 was Virtu Financial, an estimated $2.75M sold.

Based on aggregated 13F filings for Q2 2019.